Jose M. Mesa

Array ( [id] => 5613526 [patent_doc_number] => 20060115454 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-06-01 [patent_title] => 'Therapeutic RNAi agents for treating restenosis' [patent_app_type] => utility [patent_app_number] => 11/251076 [patent_app_country] => US [patent_app_date] => 2005-10-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 23458 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0115/20060115454.pdf [firstpage_image] =>[orig_patent_app_number] => 11251076 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5807689 [patent_doc_number] => 20060094043 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-05-04 [patent_title] => 'Genes displaying enhanced expression during cellular senescence and terminal cell differentiation and uses thereof' [patent_app_type] => utility [patent_app_number] => 11/242317 [patent_app_country] => US [patent_app_date] => 2005-10-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 15262 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0094/20060094043.pdf [firstpage_image] =>[orig_patent_app_number] => 11242317 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5785218 [patent_doc_number] => 20060204974 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-09-14 [patent_title] => 'Methods and agents for regulating angiotensin activity' [patent_app_type] => utility [patent_app_number] => 11/235785 [patent_app_country] => US [patent_app_date] => 2005-09-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 36 [patent_figures_cnt] => 36 [patent_no_of_words] => 29542 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0204/20060204974.pdf [firstpage_image] =>[orig_patent_app_number] => 11235785 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5704773 [patent_doc_number] => 20060193821 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-08-31 [patent_title] => 'Aptamers to the human IL-12 cytokine family and their use as autoimmune disease therapeutics' [patent_app_type] => utility [patent_app_number] => 11/234676 [patent_app_country] => US [patent_app_date] => 2005-09-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 28 [patent_no_of_words] => 50033 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0193/20060193821.pdf [firstpage_image] =>[orig_patent_app_number] => 11234676 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5107673 [patent_doc_number] => 20070066551 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-03-22 [patent_title] => 'Aptamer medicinal chemistry' [patent_app_type] => utility [patent_app_number] => 11/222466 [patent_app_country] => US [patent_app_date] => 2005-09-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 19165 [patent_no_of_claims] => 61 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0066/20070066551.pdf [firstpage_image] =>[orig_patent_app_number] => 11222466 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5844362 [patent_doc_number] => 20060122137 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-06-08 [patent_title] => '5\'-methylpyrimidine and 2\'-O-methyl ribonucleotide modified double-stranded ribonucleic acid molecules' [patent_app_type] => utility [patent_app_number] => 11/219582 [patent_app_country] => US [patent_app_date] => 2005-09-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 12710 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0122/20060122137.pdf [firstpage_image] =>[orig_patent_app_number] => 11219582 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5638077 [patent_doc_number] => 20060069051 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-03-30 [patent_title] => 'AChE antisense oligonucleotide as an anti-inflammatory agent' [patent_app_type] => utility [patent_app_number] => 11/187719 [patent_app_country] => US [patent_app_date] => 2005-07-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 21935 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0069/20060069051.pdf [firstpage_image] =>[orig_patent_app_number] => 11187719 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5769159 [patent_doc_number] => 20060019920 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-01-26 [patent_title] => 'Antisense modulation of MEKK4 expression' [patent_app_type] => utility [patent_app_number] => 11/179128 [patent_app_country] => US [patent_app_date] => 2005-07-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25478 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0019/20060019920.pdf [firstpage_image] =>[orig_patent_app_number] => 11179128 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7232893 [patent_doc_number] => 20050256051 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-11-17 [patent_title] => 'Nuclear receptor-mediated introduction of a PNA into cell nuclei' [patent_app_type] => utility [patent_app_number] => 11/167616 [patent_app_country] => US [patent_app_date] => 2005-06-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 9315 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0256/20050256051.pdf [firstpage_image] =>[orig_patent_app_number] => 11167616 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5590839 [patent_doc_number] => 20060040290 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-02-23 [patent_title] => 'Methods, compositions, and kits comprising PNA for RNA interference' [patent_app_type] => utility [patent_app_number] => 11/166031 [patent_app_country] => US [patent_app_date] => 2005-06-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 12092 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0040/20060040290.pdf [firstpage_image] =>[orig_patent_app_number] => 11166031 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5738516 [patent_doc_number] => 20060008907 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-01-12 [patent_title] => 'Control of gene expression via light activated RNA interference' [patent_app_type] => utility [patent_app_number] => 11/148891 [patent_app_country] => US [patent_app_date] => 2005-06-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 28 [patent_no_of_words] => 13078 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0008/20060008907.pdf [firstpage_image] =>[orig_patent_app_number] => 11148891 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5591430 [patent_doc_number] => 20060040882 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-02-23 [patent_title] => 'Compostions and methods for enhancing delivery of nucleic acids into cells and for modifying expression of target genes in cells' [patent_app_type] => utility [patent_app_number] => 11/121566 [patent_app_country] => US [patent_app_date] => 2005-05-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 23240 [patent_no_of_claims] => 87 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0040/20060040882.pdf [firstpage_image] =>[orig_patent_app_number] => 11121566 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 383115 [patent_doc_number] => 07307067 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-12-11 [patent_title] => 'Methods and compositions for reducing viral genome amounts in a target cell' [patent_app_type] => utility [patent_app_number] => 11/122328 [patent_app_country] => US [patent_app_date] => 2005-05-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 8922 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 65 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/307/07307067.pdf [firstpage_image] =>[orig_patent_app_number] => 11122328 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7055965 [patent_doc_number] => 20050277139 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-12-15 [patent_title] => 'Methods and apparatus for the detection and validation of microRNAs' [patent_app_type] => utility [patent_app_number] => 11/114879 [patent_app_country] => US [patent_app_date] => 2005-04-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 8440 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0277/20050277139.pdf [firstpage_image] =>[orig_patent_app_number] => 11114879 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 252816 [patent_doc_number] => 07579450 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-08-25 [patent_title] => 'Nucleic acid ligands specific to immunoglobulin E and their use as atopic disease therapeutics' [patent_app_type] => utility [patent_app_number] => 11/115780 [patent_app_country] => US [patent_app_date] => 2005-04-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 21 [patent_no_of_words] => 39206 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/579/07579450.pdf [firstpage_image] =>[orig_patent_app_number] => 11115780 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5715539 [patent_doc_number] => 20060078902 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-04-13 [patent_title] => 'Method and compositions for RNA interference' [patent_app_type] => utility [patent_app_number] => 11/105594 [patent_app_country] => US [patent_app_date] => 2005-04-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 44 [patent_figures_cnt] => 44 [patent_no_of_words] => 51940 [patent_no_of_claims] => 51 [patent_no_of_ind_claims] => 20 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0078/20060078902.pdf [firstpage_image] =>[orig_patent_app_number] => 11105594 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7219893 [patent_doc_number] => 20050260648 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-11-24 [patent_title] => 'Method for the determination of cellular transcriptional' [patent_app_type] => utility [patent_app_number] => 11/102453 [patent_app_country] => US [patent_app_date] => 2005-04-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 12157 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0260/20050260648.pdf [firstpage_image] =>[orig_patent_app_number] => 11102453 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7220740 [patent_doc_number] => 20050260755 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-11-24 [patent_title] => 'Sequential delivery of oligomeric compounds' [patent_app_type] => utility [patent_app_number] => 11/101017 [patent_app_country] => US [patent_app_date] => 2005-04-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 46980 [patent_no_of_claims] => 56 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0260/20050260755.pdf [firstpage_image] =>[orig_patent_app_number] => 11101017 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5107672 [patent_doc_number] => 20070066550 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-03-22 [patent_title] => 'Aptamers to the human IL-12 cytokine family and their use as autoimmune disease therapeutics' [patent_app_type] => utility [patent_app_number] => 11/075649 [patent_app_country] => US [patent_app_date] => 2005-03-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 23 [patent_no_of_words] => 46488 [patent_no_of_claims] => 75 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0066/20070066550.pdf [firstpage_image] =>[orig_patent_app_number] => 11075649 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7074749 [patent_doc_number] => 20050148017 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-07-07 [patent_title] => 'Antisense oligonucleotides against tenascin for the treating of vitiligo' [patent_app_type] => utility [patent_app_number] => 11/073230 [patent_app_country] => US [patent_app_date] => 2005-03-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7157 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0148/20050148017.pdf [firstpage_image] =>[orig_patent_app_number] => 11073230 [rel_patent_id] =>[rel_patent_doc_number] =>)